No abstract available
MeSH terms
-
Administration, Intravenous
-
Aged, 80 and over
-
Anticoagulants / administration & dosage*
-
Anticoagulants / adverse effects
-
Arterial Occlusive Diseases / diagnosis
-
Arterial Occlusive Diseases / drug therapy*
-
Contraindications
-
Endovascular Procedures
-
Female
-
Fibrinolytic Agents / administration & dosage
-
Humans
-
Ischemia / diagnosis
-
Ischemia / drug therapy*
-
Middle Cerebral Artery / pathology
-
Morpholines / administration & dosage*
-
Morpholines / adverse effects
-
Rivaroxaban
-
Stroke / diagnosis*
-
Stroke / drug therapy
-
Thiophenes / administration & dosage*
-
Thiophenes / adverse effects
-
Thrombolytic Therapy / methods
-
Tissue Plasminogen Activator / administration & dosage
-
Treatment Outcome
Substances
-
Anticoagulants
-
Fibrinolytic Agents
-
Morpholines
-
Thiophenes
-
Rivaroxaban
-
Tissue Plasminogen Activator